The next era of transcatheter aortic valve replacement: A case illustrating the benefit of a fully re‐positionable, re‐sheathable, and retrievable prosthesis

While transcatheter aortic valve replacement (TAVR) is an accepted treatment modality in appropriately selected patients there remain modest complication rates. New TAVR devices, through novel design features, may overcome some of these complications. We present the first case of full re‐sheathing and retrieval of a Lotus Valve to facilitate a change in prosthesis size. © 2013 Wiley Periodicals, Inc.

[1]  Susheel Kodali,et al.  Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. , 2012, The New England journal of medicine.

[2]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[3]  R. Tölg,et al.  Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. , 2010, Journal of the American College of Cardiology.

[4]  J. Fajadet,et al.  Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.